Article
Prognostic Nomogram to Predict the Overall Survival of Patients with “driver-gene-negative” Lung Adenocarcinoma (LUAD) and Its’ Biological Basis Deciphering
2021-10-07
Abstract excerpt
<h4>Objectives: </h4> Assessing the prognosis of patients with “driver-gene-negative” lung adenocarcinoma (LUAD patients negative for EGFR, KRAS, BRAF, HER2, MET, ALK, RET and ROS1 were identified as “driver-gene-negative”) is of significant clinical importance. We aimed to devise a prognostic nomogram for this LUAD subgroup and to define its biological basis. <h4>Materials: </h4> and methods: Prognostic nomogram...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f936ac22-cfa1-5211-89c7-500793ffb8ce
- DOI
- 10.21203/rs.3.rs-933879/v1
